Pre-order Enquiry
Request Free Sample
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Insights, Forecast to 2025
SKU ID : QYR-14088232 | Publishing Date : 12-Apr-2019 | No. of pages : 119
Detailed TOC of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Insights, Forecast to 2025
Table of Contents1 Study Coverage
1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by Product
1.4.2 Preface
1.4.3 Eluxadoline
1.4.4 Alosetron
1.4.5 Rifaximin
1.4.6 Loperamide
1.4.7 Diphenoxylate + Atropine
1.4.8 Dicyclomine and Hyoscyamine
1.5 Market by End User
1.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size
2.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2014-2025
2.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2014-2025
2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Growth Rate by Regions
2.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Regions
2.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers
3.1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers
3.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Manufacturers
3.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers
3.2.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Manufacturers
3.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Product
4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Product
4.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Breakdown Data by End User
6 North America
6.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countries
6.1.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries
6.1.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Product
6.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by End User
7 Europe
7.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countries
7.1.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries
7.1.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Product
7.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countries
8.1.1 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries
8.1.2 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Product
8.3 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by End User
9 Central & South America
9.1 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countries
9.1.1 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries
9.1.2 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Product
9.3 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countries
10.1.1 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries
10.1.2 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Product
10.3 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by End User
11 Company Profiles
11.1 Astellas Pharmaceuticals
11.1.1 Astellas Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
11.1.5 Astellas Pharmaceuticals Recent Development
11.2 Actavis
11.2.1 Actavis Company Details
11.2.2 Company Business Overview
11.2.3 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
11.2.5 Actavis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Business Overview
11.3.3 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
11.3.5 Pfizer Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 Company Business Overview
11.4.3 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
11.4.5 GlaxoSmithKline Recent Development
11.5 Salix Pharmaceuticals Ltd
11.5.1 Salix Pharmaceuticals Ltd Company Details
11.5.2 Company Business Overview
11.5.3 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
11.5.5 Salix Pharmaceuticals Ltd Recent Development
11.6 AstraZenenca
11.6.1 AstraZenenca Company Details
11.6.2 Company Business Overview
11.6.3 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Products Offered
11.6.5 AstraZenenca Recent Development
12 Future Forecast
12.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast by Regions
12.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Regions 2019-2025
12.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast by Product
12.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Product 2019-2025
12.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast by End User
12.4 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast
12.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast
12.6 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast
12.7 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast
12.8 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Insights, Forecast to 2025
List of Tables and FiguresFigure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Picture
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segments
Table Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Covered
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Product 2014-2025
Figure Preface Product Picture
Table Major Manufacturers of Preface
Figure Eluxadoline Product Picture
Table Major Manufacturers of Eluxadoline
Figure Alosetron Product Picture
Table Major Manufacturers of Alosetron
Figure Rifaximin Product Picture
Table Major Manufacturers of Rifaximin
Figure Loperamide Product Picture
Table Major Manufacturers of Loperamide
Figure Diphenoxylate + Atropine Product Picture
Table Major Manufacturers of Diphenoxylate + Atropine
Figure Dicyclomine and Hyoscyamine Product Picture
Table Major Manufacturers of Dicyclomine and Hyoscyamine
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Others
Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Report Years Considered
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size 2014-2025 (Million US$)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2014-2025 (K Units)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Regions 2014-2019 (K Units)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Regions 2014-2019
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Regions
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions 2014-2019
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2014-2019)
Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (2014-2019) (USD/Unit)
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
Table Date of International Manufacturers Enter into Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Product (2014-2019) (K Units)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Product (2014-2019)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Product (2014-2019)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Product in 2018
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Product (2014-2019)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Product (2014-2019)
Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Product in 2018
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by End User (2014-2019) (K Units)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by End User (2014-2019)
Figure Global Sales Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by End User (2014-2019)
Figure Global Sales Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by End User in 2018
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2014-2019) (K Units)
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries
Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Product (2014-2019) (K Units)
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Product
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by End User (2014-2019) (K Units)
Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by End User
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries
Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Product (2014-2019) (K Units)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Product
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by End User (2014-2019) (K Units)
Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by End User
Figure Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries
Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Product
Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by End User
Figure Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries
Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries
Figure Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Product
Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by End User
Figure Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries
Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries
Figure GCC Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Product
Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by End User
Table Astellas Pharmaceuticals Company Details
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharmaceuticals Recent Development
Table Actavis Company Details
Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Actavis Recent Development
Table Pfizer Company Details
Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Salix Pharmaceuticals Ltd Company Details
Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Salix Pharmaceuticals Ltd Recent Development
Table AstraZenenca Company Details
Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZenenca Recent Development
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Value Chain
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers List
Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Insights, Forecast to 2025
Astellas PharmaceuticalsActavis
Pfizer
GlaxoSmithKline
Salix Pharmaceuticals Ltd
AstraZenenca
Request Sample
Request Discount
